Latest news
Loading news…
Kymera Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Cambridge, Massachusetts, United States Founded 2017 101-250 employees For Profit
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
226
Ticker
KYMR
NASDAQ
Patents
145
19 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- KYMR
- Exchange
- NASDAQ
- IPO date
- Aug 20, 2020
- Raised at IPO
- $174M
- Valuation at IPO
- $863M
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 32
- Active products
- 22
- Patents granted
- 145
- Trademarks
- 19
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $851K
Company Info
- Founded
- 2017
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- News articles
- 302
- HQ
- Cambridge, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Aug 20, 2020
Signals & Scores
- Heat score
- Medium
- Growth score
- High
- Trend (7d)
- -0.2
- Trend (30d)
- 0.7
- Trend (90d)
- 3.4
- Last leadership hire
- Jun 8, 2026
Key People at Kymera Therapeutics
Chairman of the Board
Chief Medical Officer
Sr. Director Program Management
Founder, President and Chief Executive Officer
Senior Vice President, Development Operations
Chief Business Officer
Senior Vice President, Technical Operations
226
professional contacts at Kymera Therapeutics
Contact execs at Kymera Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Kymera Therapeutics
Loading news…
FAQs about Kymera Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.